Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio to Distribute NuGen Products

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Takara Bio will distribute NuGen's DNA and RNA sample preparation products in Japan, South Korea, and China, under a non-exclusive agreement announced today.

As part of the deal, Takara has rights to offer services using NuGen products in the same territory. Products covered under the agreement include NuGen's next-generation sequencing, microarray, and q-PCR nucleic acid amplification and sample preparation products.

"These offerings complement our current portfolio of leading products as well as custom services in molecular biology and genomics including next-generation sequencing, PCR, real-time PCR, and microarrays," Tsuyoshi Miyamura, general manager of marketing for Takara Bio, said in a statement.

San Carlos, Calif.-based NuGen said that Takara joins its network of distributors for Japan, Singapore, and Australia, as well as its service provider partners in India, China, and Taiwan.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.